Management of anaemia in haemodialysis and peritoneal dialysis patients (Chapter 8).

Forty-one percent of UK patients commence RRT with an Hb <10.0 g/dl. The mean Hb at commencement of RRT is 10.3 g/dl. Eighty-five percent of patients on dialysis in the UK have an Hb ≥ 10.0 g/dl by 6 months after commencement of RRT.The median Hb on haemodialysis in the UK is 11.8 g/dl with an IQR of 10.7–12.8 g/dl. Eighty-six percent of haemodialysis patients in the UK have a Hb ≥ 10.0 g/dl. The median Hb on peritoneal dialysis in the UK is 12.0 g/dl with an IQR of 11.0–12.9 g/dl. Ninety percent of peritoneal dialysis patients in the UK have an Hb ≥ 10.0 g/dl.In the UK, 49% of patients on PD and 48% of patients on haemodialysis have an Hb between 10.5–12.5 g/dl.The median ferritin in UK haemodialysis patients is 413 μg/l (IQR 262–623), 95% of UK haemodialysis patients have a ferritin ≥100 μg/l.The median ferritin in UK PD patients is 256 μg/l (IQR 147–421), 86% of UK peritoneal dialysis patients have a ferritin ≥ 100 μg/l.A higher proportion of HD patients than PD patients receive ESA therapy (88% vs 76%). The ESA dose is higher for HD than PD patients (9204 vs 6080 IU/week). [ABSTRACT FROM AUTHOR]